Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
Status:
Active, not recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify whether an Accelerated or Intensified Infliximab
induction regimen is superior to Standard induction in Acute Severe Ulcerative Colitis in an
open label multi-centre randomised controlled trial.